Involvement	involvement	O	O
of	of	O	O
the	the	O	O
mu-opiate	mu-opiate	O	O
receptor	receptor	O	O
in	in	O	O
peripheral	peripheral	O	O
analgesia	analgesia	O	O
.	.	O	O

The	the	O	O
intradermal	intradermal	O	O
injection	injection	O	O
of	of	O	O
mu	mu	O	O
(	(	O	O
morphine	morphine	S_chemicals	O
,	,	O	O
Tyr-D-Ala-Gly-NMe-Phe-Gly-ol	tyr-d-ala-gly-nme-phe-gly-ol	O	O
and	and	O	O
morphiceptin	morphiceptin	O	O
)	)	O	O
,	,	O	O
kappa	kappa	O	O
(	(	O	O
trans-3,4-dichloro-N-methyl-N[2-(1-pyrrolidinyl	trans-3,4-dichloro-n-methyl-n[2-(1-pyrrolidinyl	O	O
)	)	O	O
cyclohexyl]benzeneactemide	cyclohexyl]benzeneactemide	O	O
)	)	O	O
and	and	O	O
delta	delta	O	O
(	(	O	O
[D-Pen2.5]-enkephalin	[d-pen2.5]-enkephalin	O	O
and	and	O	O
[D-Ser2]-[Leu]enkephalin-Thr	[d-ser2]-[leu]enkephalin-thr	O	O
)	)	O	O
selective	selective	O	O
opioid-agonists	opioid-agonists	O	O
,	,	O	O
by	by	O	O
themselves	themselves	O	O
,	,	O	O
did	did	O	O
not	not	O	O
significantly	significantly	O	O
affect	affect	O	O
the	the	O	O
mechanical	mechanical	O	O
nociceptive	nociceptive	O	O
threshold	threshold	O	O
in	in	O	O
the	the	O	O
hindpaw	hindpaw	O	O
of	of	O	O
the	the	O	O
rat	rat	O	O
.	.	O	O

Intradermal	intradermal	O	O
injection	injection	O	O
of	of	O	O
mu	mu	O	O
,	,	O	O
but	but	O	O
not	not	O	O
delta	delta	O	O
or	or	O	O
kappa	kappa	O	O
opioid-agonists	opioid-agonists	O	O
,	,	O	O
however	however	O	O
,	,	O	O
produced	produced	O	O
dose-dependent	dose-dependent	O	O
inhibition	inhibition	O	O
of	of	O	O
prostaglandin	prostaglandin	S_chemicals	O
E2-induced	e2-induced	O	O
hyperalgesia	hyperalgesia	O	S_disease
.	.	O	O

The	the	O	O
analgesic	analgesic	S_chemicals	O
effect	effect	O	O
of	of	O	O
the	the	O	O
mu-agonist	mu-agonist	O	O
morphine	morphine	S_chemicals	O
was	was	O	O
dose-dependently	dose-dependently	O	O
antagonized	antagonized	O	O
by	by	O	O
naloxone	naloxone	O	O
and	and	O	O
prevented	prevented	O	O
by	by	O	O
co-injection	co-injection	O	O
of	of	O	O
pertussis	pertussis	B_chemicals	S_disease
toxin	toxin	I_chemicals	O
.	.	O	O

Morphine	morphine	S_chemicals	O
did	did	O	O
not	not	O	O
,	,	O	O
however	however	O	O
,	,	O	O
alter	alter	O	O
the	the	O	O
hyperalgesia	hyperalgesia	O	S_disease
induced	induced	O	O
by	by	O	O
8-bromo	8-bromo	O	O
cyclic	cyclic	O	O
adenosine	adenosine	B_chemicals	O
monophosphate	monophosphate	S_chemicals	O
.	.	O	O

We	we	O	O
conclude	conclude	O	O
that	that	O	O
the	the	O	O
analgesic	analgesic	S_chemicals	O
action	action	O	O
of	of	O	O
opioids	opioids	S_chemicals	O
on	on	O	O
the	the	O	O
peripheral	peripheral	O	O
terminals	terminals	O	O
of	of	O	O
primary	primary	O	O
afferents	afferents	O	O
is	is	O	O
via	via	O	O
a	a	O	O
binding	binding	O	O
site	site	O	O
with	with	O	O
characteristics	characteristics	O	O
of	of	O	O
the	the	O	O
mu-opioid	mu-opioid	O	O
receptor	receptor	O	O
and	and	O	O
that	that	O	O
this	this	O	O
action	action	O	O
is	is	O	O
mediated	mediated	O	O
by	by	O	O
inhibition	inhibition	O	O
of	of	O	O
the	the	O	O
cyclic	cyclic	O	O
adenosine	adenosine	B_chemicals	O
monophosphate	monophosphate	S_chemicals	O
second	second	O	O
messenger	messenger	O	O
system	system	O	O
.	.	O	O

